Mar 27, 2024
Pudong Drug Pricing Pilot
#1 Pudong reform pilot permits new drug launch pricing comparable to international markets.
On January 22nd, a joint announcement was
Kelly Ke
Mar 13, 2024
China's Basic Medical Insurance Data: Three Key Trends and Ecosystem Implications
The 2022 National Medical Security Industry Development Statistical Bulletin, along with the Basic Medical Insurance operation data for Q1 to
Feb 28, 2024
Policy Push for Long-Term Huiminbao: The Impact on Innovative Medicine
In early January, the National Administration of Financial Regulation (NAFR) issued a draft titled "Notice on Promoting the Smooth
Feb 14, 2024
China's DRG/DIP Reform: Bridging Medical Service Pricing and Supporting Tech Innovation
The DRG/DIP payment reform has curtailed the rapid expansion of China's public hospitals, shifting focus to quality
Jan 17, 2024
Closing the Affordability Gap: Can China’s Commercial Health Insurance Deliver?
At the end of 2021, individual out-of-pocket (OOP) spending in China constituted 27.7% of total healthcare expenditure (THE), soaring
Jan 03, 2024
Fair Pricing of Pharmaceuticals: Insights into China's NRDL Negotiation
Although NRDL negotiation involves multiple aspects, at its core, the most fundamental issue is the fair pricing of innovative pharmaceuticals.
Dec 20, 2023
China Market Access Pathways for Innovative Medicines Infographic
Breaking from my usual bi-weekly newsletters, I have a valuable resource for you: an infographic detailing China Market Access Pathways
Dec 06, 2023
NHSA Proposes Launch Price Framework and Aligns Pricing Policies with Drug Lifecycle
At a recent industry investor conference, Weng Linjia, Deputy Director of the Pharmaceutical Pricing and Tender Procurement Department, National Healthcare
Nov 22, 2023
China's Medical Service Pricing Reform: Current State and Future Development
In our last newsletter, we delved into the three fundamental issues connected with medical service pricing in China:
* Fragmented pricing
Nov 08, 2023
China's Medical Service Pricing Reform: 3 Core Challenges
China's medical service pricing reform is pivotal in reshaping China's healthcare landscape, impacting not only inpatient